Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -157.11% is 46% above its 1-year average of -290.05%, near the high end of its 1-year range (-771.69%–19.60%).
Reported quarterly EBITDA margin; no daily interpolation. Q4 FY2023 (2023-12-31): -422.02%.
EBITDA MARGIN
-157.11%
EBITDA MARGIN AVG TTM
N/A
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Palvella Therapeutics, Inc.
Market Cap
$1.85B
EBITDA Margin
-157.11%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.85B
EBITDA Margin
-3042.18%
TTM Avg
-3200.65%
3Y Avg
-2392.49%
5Y Avg
-2392.49%
Market Cap
$1.82B
EBITDA Margin
-27.90%
TTM Avg
-7.22%
3Y Avg
-21.35%
5Y Avg
-40.43%
Market Cap
$1.82B
EBITDA Margin
31.38%
TTM Avg
29.77%
3Y Avg
26.47%
5Y Avg
27.37%
Market Cap
$1.89B
EBITDA Margin
3.75%
TTM Avg
2.81%
3Y Avg
-0.66%
5Y Avg
-2.07%
Market Cap
$1.80B
EBITDA Margin
-132.98%
TTM Avg
-141.75%
3Y Avg
-99.37%
5Y Avg
-72.79%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Palvella Therapeutics, Inc. (PVLA) | $1.85B | -157.11% | N/A | N/A | N/A |
| Immunome, Inc. (IMNM)vs › | $1.85B | -3042.18% | -3200.65% | -2392.49% | -2392.49% |
| Astrana Health, Inc. (ASTH)vs › | $1.84B | 3.91% | 4.83% | 6.92% | 8.21% |
| Azenta, Inc. (AZTA)vs › | $1.84B | 8.41% | 9.50% | 6.21% | 7.73% |
| Sarepta Therapeutics, Inc. (SRPT)vs › | $1.82B | -27.90% | -7.22% | -21.35% | -40.43% |
| Trevi Therapeutics, Inc. (TRVI)vs › | $1.88B | N/A | N/A | N/A | N/A |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 31.38% | 29.77% | 26.47% | 27.37% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 3.75% | 2.81% | -0.66% | -2.07% |
| Xencor, Inc. (XNCR)vs › | $1.80B | -132.98% | -141.75% | -99.37% | -72.79% |
| Novavax, Inc. (NVAX)vs › | $1.80B | 52.59% | 11.61% | -27.43% | -466.07% |
Gross Margin
0.0%
EBITDA Margin
-157.1%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2023-12-31 | -422.02% |
| 2023-09-30 | 19.60% |
| 2023-06-30 | 13.90% |
| 2023-03-31 | -771.69% |
